Andrew J. Wallace

Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study

Dominic G. Rothwell, Mahmood Ayub, Natalie Cook et al. · Nature Medicine · 2019 · 306 citations · Full text

Medicine, Oncology, Radiology +10

The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome

Emma J. Crosbie, Neil Ryan, Mark J. Arends et al. · Genetics in Medicine · 2019 · 235 citations · Full text

Medicine, Gynecology, Oncology +17

Predictors of the Risk of Mortality in Neurofibromatosis 2

Michael E. Baser, Jan M. Friedman, Dana Aeschliman et al. · The American Journal of Human Genetics · 2002 · 229 citations · Full text

Medicine, Neurology, Neuroscience +10

Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.

D. Gareth Evans, L. Trueman, Andrew J. Wallace et al. · Journal of Medical Genetics · 1998 · 224 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Evaluation of clinical diagnostic criteria for neurofibromatosis 2

M E Baser, Jan M. Friedman, Andrew J. Wallace et al. · Neurology · 2002 · 221 citations

Medicine, Neurology, Otolaryngology +10